Lantern Pharma Inc (LTRN) — Cash Flow-to-Debt Ratio
Lantern Pharma Inc (LTRN) has a Cash Flow-to-Debt Ratio of -1.13x as of September 2025, meaning its operating cash flow of $-4.57 Million could theoretically repay -1% of its total liabilities ($4.04 Million) in one year. See how liquid is Lantern Pharma Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lantern Pharma Inc Cash Flow-to-Debt Ratio (2018–2024)
Historical debt coverage capacity for Lantern Pharma Inc across 7 annual periods. Also explore Lantern Pharma Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Lantern Pharma Inc (2018–2024)
Year-by-year debt coverage analysis for Lantern Pharma Inc. For market capitalisation and broader financial context, see market value of Lantern Pharma Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.06x | $-17.81 Million | $4.38 Million | ▲ +22.4% |
| 2023 | -5.24x | $-14.35 Million | $2.74 Million | ▼ -14.8% |
| 2022 | -4.56x | $-12.77 Million | $2.80 Million | ▼ -2.5% |
| 2021 | -4.45x | $-10.59 Million | $2.38 Million | ▲ +47.9% |
| 2020 | -8.55x | $-5.65 Million | $660.84K | ▼ -96.6% |
| 2019 | -4.35x | $-2.13 Million | $489.29K | ▼ -122.9% |
| 2018 | -1.95x | $-1.27 Million | $651.63K | — |